CSJA:FRA
CSL ADR
€27.60
0.00%
(0.00) 1D
Oct 12, 8:21:59 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSJA...
Mkt. cap
88.58B
Avg. vol.
10.00
Volume
0.00
52-wk high
€43.40
52-wk low
€12.70
No. of employees
29K
Mkt. cap
88.58B
Avg. vol.
10.00
Volume
0.00
52-wk high
€43.40
52-wk low
€12.70
No. of employees
29K
News stories
From web sources and news partners
Kalkine Media
·
1 hour ago
How Is ASX 200 Stock CSL (ASX:CSL) Rebuilding Plasma Growth After a Reset?
ad-hoc-news.de
·
18 hours ago
CSL stock trades at EUR 114.24 with AUD 88.5 billion market cap
ad-hoc-news.de
·
22 hours ago
CSL signs rare-disease deal and CSL stock costs EUR 114.58
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com